A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Infliximab in Chinese Subjects With Active Ulcerative Colitis.
Phase of Trial: Phase III
Latest Information Update: 27 Nov 2014
At a glance
- Drugs Infliximab (Primary)
- Indications Ulcerative colitis
- Focus Registrational; Therapeutic Use
- Sponsors Xian-Janssen
- 27 Nov 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 12 Apr 2013 Planned end date changed from 1 Jun 2014 to 1 Nov 2014 as reported by ClinicalTrials.gov.